Silab inaugurated its third production unit at its single site in Brive-la-Gaillarde (Corrèze, France) last month. This new 4,500 m2 site, the company’s fifth, gives Silab the ability to double its production capacity of biologically active molecules. A 15 million euro investment, for the most part self-funded, has gone into this new start-of-the-art industrial unit. It includes three production lines together with high-tech equipment that combines flexibility and automation. Computeri...